Red Biotechnology Market By Application (Biopharmaceutical Manufacture, Pharmacogenomics, Gene Therapy, and Genetic Testing), By End-user (Biopharmaceutical Business, Research Organizations, CMOs & CROs, and Others), and By Region - Market Trends, Analysis, and Forecast till 2029

Red biotechnology market was valued at US$ 353.1 billion in 2019 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% to reach US$ 584.8 billion by 2029.

Among the subfields of biotechnology is red biotechnology. Global biotechnology is growing as a result of global advancements. The fields of pharmaceuticals, health preservation, and human healthcare are all included in red biotechnology. To create and produce new therapeutics, vaccines, antibiotics, and diagnostic techniques, scientists take advantage of biological systems. It is the area of study that covers genetic testing, gene therapy, pharmacogenomics, personalized medicine, and drug discovery. Red biotechnology is also used in the manufacture of biochips and in the study of cancer.